Veterinary Imaging Market

Executive Summary

Veterinary Imaging Market was valued at US $1.71 billion in 2021 and is projected to grow at 6.91% CAGR over the forecast period to reach US $2.55 billion by 2027. Veterinary Imaging Market represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.84 billion opportunity in 2027 over 2021.

Veterinary Imaging from Consainsights analyses the Veterinary Imaging Market in the Life Sciences industry over the forecast period to 2027.

Veterinary Imaging research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Veterinary Imaging segmentation includes Product, Animal Type, Therapeutic Area, End User and Geography.

Based on the Product, the Veterinary Imaging analysis covers Instruments, Veterinary Imaging Reagents, Veterinary Software.

In Product segment, Instruments segment has highest cagr growth of 6.12%.

Based on the Animal Type, the Veterinary Imaging analysis covers Small Companion Animals, Large Animals, Other Animals.

In Animal Type segment, Small Companion Animals segment has highest cagr growth of 6.12%.

Based on the Therapeutic Area, the Veterinary Imaging analysis covers Orthopedics And Traumatology, Oncology, Cardiology, Neurology, Other Therapeutic Areas.

In Therapeutic Area segment, Orthopedics And Traumatology segment has highest cagr growth of 6.12%.

Based on the End User, the Veterinary Imaging analysis covers Clinics, Hospitals & Academic Institutions.

In End User segment, Clinics segment has highest cagr growth of 6.12%.

Based on the region, the Veterinary Imaging analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Ge Healthcare (A Division Of General Electric Company), Agfa-gevaert N.V., Excelsior Union Limited (Mindray Medical International Limited), Onex Corporation (Carestream Health, Inc.), Esaote Spa, Canon Inc. (Toshiba Medical Systems Corporation), Idexx Laboratories, Inc., Vca Inc., Hitachi, Ltd., Siemens Ag, Fujifilm Holdings Corporation, Bcf Technology, Ltd. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Instruments segment has the highest revenue of US $0.81 billion and is expected to grow at CAGR of 6.12% by 2027 Instruments segment has highest cagr growth of 6.12%.

Instruments

Instruments segment was valued at US $0.71 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $1.21 billion by 2027. Instruments segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.40 billion opportunity in 2027 over 2021.

Veterinary Imaging Reagents

Veterinary Imaging Reagents segment was valued at US $0.53 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.90 billion by 2027. Veterinary Imaging Reagents segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.30 billion opportunity in 2027 over 2021.

Veterinary Software

Veterinary Software segment was valued at US $0.26 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.44 billion by 2027. Veterinary Software segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.15 billion opportunity in 2027 over 2021.

Animal Type

Introduction

In 2021, Small Companion Animals segment has the highest revenue of US $0.70 billion and is expected to grow at CAGR of 6.12% by 2027 Small Companion Animals segment has highest cagr growth of 6.12%.

Small Companion Animals

Small Companion Animals segment was valued at US $0.61 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $1.04 billion by 2027. Small Companion Animals segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.34 billion opportunity in 2027 over 2021.

Large Animals

Large Animals segment was valued at US $0.57 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.97 billion by 2027. Large Animals segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.

Other Animals

Other Animals segment was valued at US $0.32 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.55 billion by 2027. Other Animals segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.18 billion opportunity in 2027 over 2021.

Therapeutic Area

Introduction

In 2021, Orthopedics And Traumatology segment has the highest revenue of US $0.69 billion and is expected to grow at CAGR of 6.12% by 2027 Orthopedics And Traumatology segment has highest cagr growth of 6.12%.

Orthopedics And Traumatology

Orthopedics And Traumatology segment was valued at US $0.60 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $1.02 billion by 2027. Orthopedics And Traumatology segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.34 billion opportunity in 2027 over 2021.

Oncology

Oncology segment was valued at US $0.36 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.61 billion by 2027. Oncology segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.20 billion opportunity in 2027 over 2021.

Cardiology

Cardiology segment was valued at US $0.29 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.50 billion by 2027. Cardiology segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Neurology

Neurology segment was valued at US $0.12 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.20 billion by 2027. Neurology segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Other Therapeutic Areas

Other Therapeutic Areas segment was valued at US $0.12 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.21 billion by 2027. Other Therapeutic Areas segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Clinics segment has the highest revenue of US $1.05 billion and is expected to grow at CAGR of 6.12% by 2027 Clinics segment has highest cagr growth of 6.12%.

Clinics

Clinics segment was valued at US $0.92 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $1.57 billion by 2027. Clinics segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.52 billion opportunity in 2027 over 2021.

Hospitals & Academic Institutions

Hospitals & Academic Institutions segment was valued at US $0.57 billion in 2019 and is projected to grow at 6.12% CAGR over the forecast period to reach US $0.98 billion by 2027. Hospitals & Academic Institutions segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.